Browse articles from EyeWorld.org related to keratoconus. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Positive topline results for Phase 3 trial of drug for allergic conjunctivitis
➤ Phase 2 trial of progesterone topical gel for DED begins
➤ Breakthrough Device Designation granted to remote glaucoma management system
➤ Glaukos enters into licensing agreement for presbyopia treatment
➤ Increase in laser vision correction procedures continues
➤ Guide on climate change and eye health
➤ ASCRS events
➤ FDA approves enhanced monovision IOL
➤ Report: Demand for refractive surgery up amid pandemic
➤ Study: Antifibrotic activity of rho-kinase inhibitors
➤ Companies partner to explore nanoparticle applications for ophthalmic therapies
➤ ASCRS Journal Club on April 8
Clara C. Chan, MD
Cornea Editor
Cornea Editor Clara Chan, MD, previews the topics that are explored in the section, including Demodex, vernal conjunctivitis, herpes zoster, and keratoconus screening.
Screening and early diagnosis is very important for keratoconus patients. Two physicians discussed when to screen, what tests they use, and treatment options.
➤ PMA submitted to FDA for small-aperture IOL
➤ Preclinical results for new class of non-prostaglandin analogs for IOP lowering
➤ A Phase 2 clinical trial begins enrollment for topical presbyopia-correcting drop
➤ Home OCT technology used in clinical trial to reduce participant visits to offices
➤ ASCRS Journal Club on March 11
➤ 2021 ASCRS Annual Meeting update
➤ FDA approves new monofocal IOL
➤ First patient dosed in Phase 2 trial for investigational DED therapy
➤ Phase 2a trial initiated for add-on wet AMD therapy
When will my vision stabilize after crosslinking? Could my keratoconus symptoms return? What complications might occur? Patients undergoing crosslinking have many questions, and CXL pros have the answers.
